Innoviva INVA
NASDAQ INVA
$20.66 -0.40 (-1.90%)
At close: Oct 23, 2026 · 4:00 PM EDT

Innoviva (INVA) Gains from Equity Investments (2022 - 2026)

Updated

Analysis

Innoviva (INVA) Gains from Equity Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Innoviva 1.50 Bn -790.08 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -131.83 Mn
Mar 31, 2026 157.65 Mn
Dec 31, 2025 111.15 Mn
Sep 30, 2025 30.75 Mn
Jun 30, 2025 13.08 Mn
Mar 31, 2025 -13.55 Mn
Dec 31, 2024 -21.26 Mn
Sep 30, 2024 -18.23 Mn
Jun 30, 2024 -60.11 Mn
Mar 31, 2024 35.34 Mn
Sep 30, 2023 71.98 Mn
Jun 30, 2023 -19.91 Mn
Mar 31, 2023 15.82 Mn
Sep 30, 2022 10.30 Mn
Jun 30, 2022 -42.82 Mn
Mar 31, 2022 -11.95 Mn
API Access

Innoviva Gains from Equity Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=INVA&period=max&api_key=YOUR_API_KEY